Latest releases

Here you can find all releases distributed by Lundbeck since 1998.

Sign-up to our subscription service to receive releases by e-mail.

Search releases

In danish
Show all releases

Corporate Releases

Press Releases

July 2, 2009 | 13:00
Lu AA24530 shows positive results in major depressive disorder phase II study

June 25, 2009 | 18:15
Lundbeck receives FDA Complete Response Letter on Serdolect® for the treatment of schizophrenia

June 11, 2009 | 23:00
Update on Lundbeck Inc. (USA)

June 8, 2009 | 08:30
Update on Lu AA21004 clinical development programme in major depressive disorder (MDD)

May 18, 2009 | 08:30
Lundbeck provides update on NDA for Serdolect® for the treatment of schizophrenia

May 13, 2009 | 08:00
First quarter 2009 report. Double digit revenue growth. Strong performance by key products

April 21, 2009 | 15:59
H. Lundbeck A/S held its Annual General Meeting on 21 April 2009 at the company's registered office

April 8, 2009 | 01:56
FDA Advisory Committee provides opinion on Serdolect® for the treatment of schizophrenia

April 2, 2009 | 10:00
Notice of the annual general meeting

March 19, 2009 | 13:00
Lundbeck's acquisition of Ovation Pharmaceuticals cleared by US Federal Trade Commission

March 12, 2009 | 18:04
Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

March 9, 2009 | 13:58
Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

March 4, 2009 | 08:00
Annual report 2008 - Lundbeck meets all of its financial forecasts for 2008 and expects continuing growth in 2009

February 9, 2009 | 13:00
Lundbeck to acquire US-based Ovation Pharmaceuticals, Inc. - a specialty pharmaceutical company focusing on central nervous system disorders (CNS)

January 27, 2009 | 10:00
Lundbeck to divest non-strategic investments to the Lundbeck Foundation

January 29, 2009 | 08:00
Lundbeck recording growth in Spain - strong growth propels escitalopram to a market-leading position

January 14, 2009 | 08:00
Lundbeck to intensify focus on new products

January 7, 2009 | 08:00
Lundbeck appoints new and experienced HR manager


H. Lundbeck A/S
Ottiliavej 9
DK-2500 Copenhagen Valby
Phone +45 3630 1311
Fax +45 3630 1940
information@lundbeck.com
The specialist in psychiatry and pioneer in neurology
Disclaimer